A Study to Assess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male and Female Subjects of Ascending Multiple Oral Doses of ASP3652

NCT02243657 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Pharmacokinetics of ASP3652
Pharmacodynamics of ASP3652

Interventions

DRUG: ASP3652
DRUG: Placebo

Sponsor

Astellas Pharma Europe B.V.